BOIRF Stock - Boiron S.A.
Unlock GoAI Insights for BOIRF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $487.56M | $493.25M | $534.24M | $455.20M | $513.58M |
| Gross Profit | $358.76M | $358.08M | $379.73M | $327.62M | $394.74M |
| Gross Margin | 73.6% | 72.6% | 71.1% | 72.0% | 76.9% |
| Operating Income | $15.74M | $42.29M | $63.45M | $46.84M | $38.19M |
| Net Income | $11.34M | $35.83M | $44.67M | $28.56M | $26.21M |
| Net Margin | 2.3% | 7.3% | 8.4% | 6.3% | 5.1% |
| EPS | $0.65 | $2.06 | $2.57 | $1.63 | $1.50 |
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Visit WebsiteEarnings History & Surprises
BOIRFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 18, 2025 | — | — | — | — |
Q2 2025 | Apr 3, 2025 | — | $0.48 | — | — |
Q3 2024 | Sep 19, 2024 | — | $0.21 | — | — |
Q2 2024 | Apr 2, 2024 | — | $1.29 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.97 | — | — |
Q4 2022 | Dec 31, 2022 | — | $1.99 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.75 | — | — |
Q4 2021 | Dec 31, 2021 | — | $2.46 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.64 | — | — |
Q4 2020 | Dec 31, 2020 | — | $1.90 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.06 | — | — |
Q4 2019 | Dec 31, 2019 | — | $2.66 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.03 | — | — |
Q4 2018 | Dec 31, 2018 | — | $2.44 | — | — |
Q2 2018 | Jun 30, 2018 | — | $1.39 | — | — |
Q4 2017 | Dec 31, 2017 | — | $3.40 | — | — |
Q2 2017 | Jun 30, 2017 | — | $1.54 | — | — |
Q4 2016 | Dec 31, 2016 | — | $2.92 | — | — |
Q2 2016 | Jun 30, 2016 | — | $1.60 | — | — |
Q4 2015 | Dec 31, 2015 | — | $3.11 | — | — |
Latest News
Frequently Asked Questions about BOIRF
What is BOIRF's current stock price?
What is the analyst price target for BOIRF?
What sector is Boiron S.A. in?
What is BOIRF's market cap?
Does BOIRF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BOIRF for comparison